PPAR-γ activation inhibits angiotensin II synthesis, apoptosis, and proliferation of mesangial cells from spontaneously hypertensive rats

Nephron - Experimental Nephrology

Volumn 106, Issue 4, 2007, Pages

  Efrati, Shai ^a,b   Berman, Sylvia ^a,b   Ilgiyeav, Eduard ^a,b   Averbukh, Zhan ^a,b   Weissgarten, Joshua ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angiotensin II; Apoptosis, mesangial cells; Hypertension; Inflammation; Peroxisome proliferator activated receptor gamma; Proliferation, mesangial cells; Rosiglitazone; Spontaneously hypertensive rat, mesangial cells

Indexed keywords

ANGIOTENSIN II; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; THYMIDINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; APOPTOSIS; ARTICLE; BLOOD PRESSURE REGULATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; ESSENTIAL HYPERTENSION; HIGH SODIUM INTAKE; HORMONE DETERMINATION; HORMONE SYNTHESIS; MALE; MESANGIUM CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RENAL PROTECTION; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; MESANGIAL CELLS; PPAR GAMMA; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES;

EID: 34547445697     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104834     Document Type: Article

References (24)

1. Obata J, Nakamura T, Takano H, Naito A, Kimura H, Yoshida Y, Shimizu F, Guo DF, Inagami T: Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000;18:1247-1255.
2. Bunkenburg B, Schnell C, Baum HP, Cumin F, Wood JM: Prolonged angiotensin II antagonism in spontaneously hypertensive rats: hemodynamic and biochemical consequences. Hypertension 1991;18:278-288.
3. Klahr S, Morrissey J: Angiotensin II and gene expression in the kidney. Am J Kidney Dis 1998;31:171-176.
4. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J: Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001;10:321-329.
5. Klahr S, Morrissey J: Progression of chronic renal disease. Am J Kidney Dis 2003;41(3 suppl 1):S3-S7.
6. Klahr S: Progression of chronic renal disease. Heart Dis 2001;3:205-209.
7. Taal MW, Brenner BM: Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int 2000;57:1803-1817.
8. Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999;20:649-688.
9. Nicholas SB, Kawano J, Wakino S, Collins AR, Hsueh WA: Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells. Hypertension 2001;37(2 Part 2):722-727.
10. Hsueh WA, Nicholas SB: Peroxisome proliferator-activated receptor-gamma in the renal mesangium. Curr Opin Nephrol Hypertens 2002;11:191-195.
11. Walker AB, Chattington PD, Buckingham RE, Williams G: The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes 1999;48:1448-1453.
12. Baylis C, Atzpodien EA, Freshour G, Engels K: Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity. J Pharmacol Exp Ther 2003;307:854-860.
13. Benkirane K, Amiri F, Diep QN, El Mabrouk M, Schiffrin EL: PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4EBP1. Am J Physiol Heart Circ Physiol 2006;290:H390-H397.
14. Benkirane K, Viel EC, Amiri F, Schiffrin EL: Peroxisome proliferator-activated receptor gamma regulates angiotensin II-stimulated phosphatidylinositol 3-kinase and mitogen-activated protein kinase in blood vessels in vivo. Hypertension 2006;47:102-108.
15. Weissgarten J, Berman S, Efrati S, Rapoport M, Averbukh Z, Feldman L: Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats. Nephrol Dial Transplant 2006;21:1198-1204.
16. Weissgarten J, Modai D, Berman S, Efrati S, Golik A, Cohen N, Cohn M, Galperin E, Averbukh Z: Hypertension but not sodium intake determines progression of renal failure in experimentally uremic rats. Nephron Physiol 2004;98:p1-p7.
17. Weissgarten J, Berman S, Efrati S, Rapoport M, Cohn M, Modai D, Averbukh Z: Apoptosis and proliferation of mesangial cells isolated from kidneys undergoing compensatory growth following contralateral nephrectomy: role of the renin-angiotensin system. Med Sci Monit 2007;13:BR16-BR23.
18. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
19. Kurogi Y: Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med Res Rev 2003;23:15-31.
20. Del Prete D, Anglani F, Ceol M, D'Angelo A, Forino M, Vianello D, Baggio B, Gambaro G: Molecular biology of diabetic glomerulosclerosis. Nephrol Dial Transplant 1998;13(suppl 8):20-25.
21. Shiojiri T, Wada K, Nakajima A, Katayama K, Shibuya A, Kudo C, Kadowaki T, Mayumi T, Yura Y, Kamisaki Y: PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice. Eur J Pharmacol 2002;448:231-238.
22. Müller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC: NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000;35(1 Pt 2):193-201.
23. Zhang SL, Guo J, Moini B, Ingelfinger JR: Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis. Kidney Int 2004;66:2181-2192.
24. Dworkin LD, Benstein JA, Tolbert E, Feiner HD: Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease. J Am Soc Nephrol 1996;7:437-442.